Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

611 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Varicella vaccines.
Javed S, Javed SA, Tyring SK. Javed S, et al. Curr Opin Infect Dis. 2012 Apr;25(2):135-40. doi: 10.1097/QCO.0b013e32834c1863. Curr Opin Infect Dis. 2012. PMID: 22123665 Review.
Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.
Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, Jones T, Rea T, Boon R, Saltzman R. Tyring S, et al. Ann Intern Med. 1995 Jul 15;123(2):89-96. doi: 10.7326/0003-4819-123-2-199507150-00002. Ann Intern Med. 1995. PMID: 7778840 Clinical Trial.
Early treatment of herpes zoster.
Tyring SK. Tyring SK. Hosp Pract (1995). 1996 Jul 15;31(7):137-44. doi: 10.1080/21548331.1996.11443319. Hosp Pract (1995). 1996. PMID: 8682880 Review.
Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group.
Reitano M, Tyring S, Lang W, Thoming C, Worm AM, Borelli S, Chambers LO, Robinson JM, Corey L. Reitano M, et al. J Infect Dis. 1998 Sep;178(3):603-10. doi: 10.1086/515385. J Infect Dis. 1998. PMID: 9728526 Clinical Trial.
Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older.
Tyring SK, Beutner KR, Tucker BA, Anderson WC, Crooks RJ. Tyring SK, et al. Arch Fam Med. 2000 Sep-Oct;9(9):863-9. doi: 10.1001/archfami.9.9.863. Arch Fam Med. 2000. PMID: 11031393 Clinical Trial.
A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
Tyring S, Belanger R, Bezwoda W, Ljungman P, Boon R, Saltzman RL; Colaborative Famciclovir Immunocompromised Study Group. Tyring S, et al. Cancer Invest. 2001;19(1):13-22. doi: 10.1081/cnv-100000070. Cancer Invest. 2001. PMID: 11291551 Clinical Trial.
Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.
Wu JJ, Brentjens MH, Torres G, Yeung-Yue K, Lee P, Tyring SK. Wu JJ, et al. J Cutan Med Surg. 2003 Sep-Oct;7(5):372-81. doi: 10.1007/s10227-002-0140-3. Epub 2003 Sep 24. J Cutan Med Surg. 2003. PMID: 14505192 Review.
Recommendations for the management of herpes zoster.
Dworkin RH, Johnson RW, Breuer J, Gnann JW, Levin MJ, Backonja M, Betts RF, Gershon AA, Haanpaa ML, McKendrick MW, Nurmikko TJ, Oaklander AL, Oxman MN, Pavan-Langston D, Petersen KL, Rowbotham MC, Schmader KE, Stacey BR, Tyring SK, van Wijck AJ, Wallace MS, Wassilew SW, Whitley RJ. Dworkin RH, et al. Clin Infect Dis. 2007 Jan 1;44 Suppl 1:S1-26. doi: 10.1086/510206. Clin Infect Dis. 2007. PMID: 17143845 Review.
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial.
Mark KE, Corey L, Meng TC, Magaret AS, Huang ML, Selke S, Slade HB, Tyring SK, Warren T, Sacks SL, Leone P, Bergland VA, Wald A. Mark KE, et al. J Infect Dis. 2007 May 1;195(9):1324-31. doi: 10.1086/513276. Epub 2007 Mar 16. J Infect Dis. 2007. PMID: 17397003 Clinical Trial.
Open-label study of valacyclovir 1.5 g twice daily for the treatment of uncomplicated herpes zoster in immunocompetent patients 18 years of age or older.
Madkan VK, Arora A, Babb-Tarbox M, Aboutlabeti S, Tyring S. Madkan VK, et al. J Cutan Med Surg. 2007 May-Jun;11(3):89-98. doi: 10.2310/7750.2007.00016. J Cutan Med Surg. 2007. PMID: 17511925 Clinical Trial.
611 results
Jump to page